Creating a Platform to Cure the Most Difficult Diseases

Summary

MiCAN will accelerate infectious disease research through special cells created with regenerative medicine technology. Many bio ventures are focusing on transplantation material or tissue using regenerative medicine technologies. But we focus on immature or intermediate blood cells that are difficult to collect from donor blood. Initially we are developing our products for infectious disease. One of our core technologies is the differentiation methods how to provide these young cells. Most of our customers are in abroad because of the target disease. So, we will provide our product from Japan to all over the world.

Ask

  • marketmarket

Company Profile

Name MiCAN Technologies Inc.
Address KKVP206, Goryo-ohara 1-36, Nshigyo-Ku, Kyoto, 615-8245, Japan
Telephone
URL http://www.micantechnologies.com/
Establishment July, 2016
Capital JPY 15,580,000
Employee 4
Branch Office
Category Bio

Team

KAZUO MIYAZAKI

CEO

MBA

Background: Drug researcher at Pharma Co.
Expertise: Small molecule drugs / Regenerative Medicine

MINORU OKADA

CTO

PhD

Background: Product development at Pharma Co.
Expertise: Cell engineering / Regenerative Medicine

Funding

Date Round Amount Investors
Angel

Contact